Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials

References

Page 1

	Year	Citations
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION GRUPPOITALIANOPERLOSTUDIODELL The Lancet ThrombosisCardiovascular DiseaseMedicineAnticoagulantCardiology	1986	2.5K
A Suggestion for Using Powerful and Informative Tests of Normality Ralph B. D’Agostino, Albert J. Belanger, Ralph B. D’Agostino The American Statistician Normal Probability PlottingEngineeringGeneralizability TheoryVerificationDiagnosis	1990	1.6K
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation David A. Morrow, Elliott M. Antman, Andrew Charlesworth, Circulation	2000	1.6K
Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction New England Journal of Medicine	1989	1K
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction Eric J. Topol, Robert M. Califf, Barry S. George, New England Journal of Medicine	1987	945
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction The Lancet ThrombosisCardiovascular DiseaseHeparin VsCardiologyRandomised Comparison	1992	920
MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction GRUPPOITALIANOPERLOSTUDIODELL The Lancet ThrombosisHeparin VersusCardiovascular DiseaseMedical Science Gissi-2Cardiology	1990	911
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION D Hunt, George Varigos, F Dienstl, Oxford University Research Archive (ORA) (University of Oxford) ThrombosisCardiovascular DiseaseCardiologyAcute Myocardial InfarctionPlatelet Antagonist	1992	898
THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY M. L. Simoons The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseCoronary Artery DiseaseFibrinolysis	1988	660
A Suggestion for Using Powerful and Informative Tests of Normality Ralph B. D’Agostino, Albert J. Belanger, Ralph B. D’Agostino The American Statistician EngineeringTesting TechniqueGeneralizability TheoryVerificationDiagnosis	1990	553

Page 1